New Zealand-based SPEL Group has announced a major advancement in infection prevention with the launch of its SPEL-MIC™ technology, a next-generation antimicrobial solution that physically destroys bacteria and viruses on contact—offering long-lasting protection without the use of chemicals or heavy metals.
Unlike traditional antimicrobial agents that rely on chemical leaching or toxic additives, SPEL-MIC™ utilizes a mechanically-active surface technology that ruptures the cell walls of microbes upon contact. This physical mode of action ensures continuous antimicrobial efficacy without contributing to resistance development—an increasingly urgent concern in global public health.
“Our goal was to develop a non-toxic, durable, and highly effective antimicrobial solution that could be applied across a wide range of surfaces—from medical devices to everyday textiles—without compromising safety or sustainability,” said Dr. Yang Fong (Richard), Chief Scientific Officer at SPEL Group. “SPEL-MIC™ represents a paradigm shift: instead of killing microbes with chemicals, we’re mechanically neutralizing them at the surface level.”
Key Features of SPEL-MIC™:
Mechanical antimicrobial action: Disrupts microbial cell walls through surface microstructures.
Non-leaching & chemical-free: No release of active substances, ensuring environmental safety.
Long-lasting protection: Effective for months or more, depending on application.
Resistance-proof: No contribution to antimicrobial resistance (AMR).
Broad-spectrum efficacy: Proven effective against bacteria, fungi, and viruses, including enveloped viruses such as influenza and coronaviruses.
The technology has already passed rigorous testing in independent laboratories and is being prepared for commercial rollout across healthcare, hospitality, and consumer product sectors. SPEL Group is currently in discussions with global partners to integrate SPEL-MIC™ into wound care dressings, hospital surfaces, air filtration systems, and antimicrobial coatings.
“This is more than just a product—it’s a platform technology,” added Dr. Fong. “We believe SPEL-MIC™ has the potential to redefine hygiene standards in both clinical and everyday environments.”
As the world continues to grapple with the dual challenges of infectious disease control and antimicrobial resistance, innovations like SPEL-MIC™ offer a powerful, future-ready solution.
About SPEL Group
SPEL Group is a New Zealand-based science and innovation company specializing in advanced antimicrobial, antiviral, and hygiene technologies. With a strong focus on non-toxic, sustainable solutions, SPEL develops technologies that protect public health across medical, industrial, and consumer applications.
